Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: a nationwide study

CONCLUSIONS: SARS CoV-2 vaccine-induced liver injury is heterogeneous but mostly immune-mediated. Relapse of liver injury after re-exposure to vaccine is frequent (28.0%) but mild. Immunosuppression at booster administration is associated with a lower risk of liver injury.PMID:38403068 | DOI:10.1016/j.aohep.2024.101489

Source: Annals of Hepatology - February 25, 2024 Category: Gastroenterology Authors: Ana Barreira-D íaz Mar Riveiro-Barciela Eva Mar ía Fernández-Bonilla Vanesa Bernal Agust ín Castiella Marta Casado-Mart ín Carolina Delgado Mar ía-Carlota Londoño Álvaro Díaz-González Indhira P érez-Medrano Andr és Conthe Margarita Sala Beatri Source Type: research